Bortezomib Treatment Of Primitive Quiescent CD34+ Cell S In Chronic Myeloid Leukemia Enhances Targeting By In Vitro Expanded Allogeneic Natural Killer Cell S

✍ Scribed by A.S.M. Yong; K. Keyvanfar; N. Hensel; R. Eniafe; B.N. Savani; M. Berg; A. Lundqvist; S. Adams; E.M. Sloand; J.M. Goldman; R. Childs; A.J. Barrett

• Book ID: 116280887
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 77 KB
• Volume: 15
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2008.12.388